# PFR Life Science

> PFR Life Science is a VC fund backing Biotechnology, Medical and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 2
- Last investment: Aug 2021
- Lead investor: 50%
- Last updated: Aug 2026

PFR Life Science is a portfolio company of one of the funds partially managed by PFR.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Poland | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Proteon Pharmaceuticals | PROTEON uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics. We have developed a platform to develop and deliver bacteriophages for animal health solutions. Our pipeline includes solutions to prophylactically improveperformance and food safety in poultry, as well as important prevent economically important bacterial diseases in aquaculture and dairy. | $24.6M | Venture - Series Unknown | Aug 10, 2021 |  |
| Proteon Therapeutics | Proteon Therapeutics, Inc is a biopharmaceutical company developing pharmaceuticals to address the medical needs of patients with renal and vascular diseases.The company leverages a unique understanding of tissue remodeling to develop a pipeline of proprietary therapeutics.Proteon Therapeutics’ first drug candidate (PRT-201) is indevelopment for the improvement of blood flow following vascular surgery procedures. The company’s initial clinical focus is vascular access for hemodialysis and peripheral arterial disease (PAD). | $24.6M | Post-IPO Equity | Aug 10, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Aqua Spark](https://shizune.co/investors/profile/aqua-sparks) — VC Fund, 3 deals together
- [Seventure Partners](https://shizune.co/investors/profile/seventure-partners) — VC Fund, 3 deals together
- Nutreco — VC Fund, 2 deals together
- Montis Capital — VC Fund, 1 deal together
- [Montis Capital Group](https://shizune.co/investors/profile/montis-capital-group) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does PFR Life Science invest in?

PFR Life Science invests primarily in Biotechnology, Medical and Pharmaceutical startups, most often at Post-IPO Equity and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did PFR Life Science last invest?

The most recent investment recorded for PFR Life Science closed in Aug 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co